These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. [The relationship between epilepsy, systemic lupus erythematosus and anticonvulsant therapy]. Leövey A; Petrányi G; Gyula S Orv Hetil; 1966 Sep; 107(38):1785-6. PubMed ID: 5974945 [No Abstract] [Full Text] [Related]
14. [Relation of hydantoin preparations to the development of disseminated lupus erythematosus]. Strejcek J; Hrbková M Cas Lek Cesk; 1965 Oct; 104(42):1158-61. PubMed ID: 5850713 [No Abstract] [Full Text] [Related]
16. [A case of systemic lupus erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment]. Wakasugi M; Sato T; Maruyama Y; Ueno M; Arakawa M Ryumachi; 1996 Jun; 36(3):545-50. PubMed ID: 8779791 [TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children. Beernink DH; Miller JJ J Pediatr; 1973 Jan; 82(1):113-7. PubMed ID: 4564576 [No Abstract] [Full Text] [Related]
19. Ethosuximide-induced de novo systemic lupus erythematosus with anti-double-strand DNA antibodies: a case report with definite evidence. Crespel A; Velizarova R; Agullo M; Gélisse P Epilepsia; 2009 Aug; 50(8):2003. PubMed ID: 19682032 [No Abstract] [Full Text] [Related]
20. [Dermatologic complications during the administration of hydantoin compounds (review)]. Gottwald W Z Haut Geschlechtskr; 1969 Jul; 44(13):471-90. PubMed ID: 4243325 [No Abstract] [Full Text] [Related] [Next] [New Search]